Navigation Links
Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008
Date:5/15/2008

646,651 1,155,907 78.8%

Revenue per visit (d) $101 $103 2.0%

Adjusted EBITDA (,000) $17,618 $20,097 14.1%

Adjusted EBITDA margin 15.7% 11.9% (24.2)%

(a) Specialty hospitals consist of long-term acute care hospitals and

acute medical rehabilitation hospitals.

(b) Net revenue per patient day is calculated by dividing specialty

hospital inpatient service revenues by the total number of patient

days.

( c ) Adjusted EBITDA margin - same store hospitals represents the

Adjusted EBITDA margin for those hospitals opened or acquired before

January 1, 2007 and operated throughout both periods.

(d) Net revenue per visit is calculated by dividing outpatient

rehabilitation clinic revenue by the total number of visits. For

purposes of this computation, outpatient rehabilitation clinic

revenue does not include managed clinics or contract services

revenue.

IV. Net Income to Adjusted EBITDA Reconciliation

(In thousands)

(unaudited)

For the Three Months Ended March 31, 2007 and 2008

The following table reconciles net income to Adjusted EBITDA for Select.

Adjusted EBITDA is used by Select to report its segment performance in

accordance with SFAS No. 131. Adjusted EBITDA is defined as net income

before interest, income taxes, depreciation and amortization, stock

compensation expense, other expense and minority interest. We believe that

the presentation of Adjusted EBITDA is important to investors because

Adjusted EBITDA is used by management to evaluate financial performance

and determine resource allocation for each of our operating units.

Adjusted EBITDA is not a measure of financial performance under

generally accepte
'/>"/>

SOURCE Select Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Brooke Franchise Corporation Announces Selected July Results
2. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
3. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
4. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
5. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
6. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
7. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
8. Harvard Researchers Select S.C. BlueCross for National Honor
9. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
10. Fry Construction Selected for High-Profile Medical Imaging Project
11. Meth Project Advertisements Selected for National Prevention Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...July 9 /PRNewswire/ -- leViv, Inc. (http://www.le... nutrition and lifestyle programs for,individual h.... The new,programs include 28-days of delicious, d...r 110 items in every order), online recipes, healt...urces, professional advice,news, health informati...
(Date:7/9/2008)... /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE...s to the global life,sciences markets, today annou...mited (AECL) with notice of arbitration proceeding...fulfill its contractual obligations,under its 2006...d if not,granted, seeking significant monetary dam...
(Date:7/9/2008)... adds to its unparalleled content on breastfeeding... professional articles on child, health, from alle...lking., BOULDER, Colo., July 9 /PRNewswire/ -- Br...verything for the New Mom, improves its already,un... doctor-reviewed,professional articles on infant, ...
(Date:7/9/2008)... DRE, Inc., a premier international surgical...mers that as much as $250,000 in medical equipment...lings. , Louisville, KY (...f 2008, in accordance with Tax Code Section 179, c...t bought in 2008. This could make 2008 an attracti...
Breaking Medicine News(10 mins):Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 2Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
...ced which has been found to have less side effects...mmunotherapy vaccines. //Antibodies against the al...nt encounters the allergen or infection these anti...o counteract the allergen which is an antigen. Co...
...n at University of California, San Francisco have ...innovative devices to first remove and then recons...ccess tumors. // Tumors which are present in the b...cult to operate. The neurosurgeon used a new tec...
...igration/Macrophage Inhibitory factor (MIF) which ...ultiple Sclerosis. This new pathway can be used in...in a way progression of Multiple Sclerosis is hind.... Multiple Sclerosis is an autoimmune disease wh...
...t tiagabine, a selective ?-aminobutyric acid (GABA... and next-morning alertness and performance in adu...mnia is characterized by difficulty initiating or ...sleep, which causes clinically significant distres...
Other Medicine News:Health News:Oral Edible vaccine for Allergy Vaccines 2Health News:Macrophage Inhibitory Factor Causes Multiple Sclerosis Progression 2
(Date:7/7/2008)...s scientific evidence supporting accuracy of, it...ajor international co...ly 7 /- Molecular,Biometrics, LLC, a ...el,clinical tools for applications in personalized... function in health and disease, presented data fr...
(Date:7/7/2008)...- Biopure Corporation,(Nasd...sions with the Food,and Drug Administration (FDA) ...r a new clinical trial of Hemopure(R) [hemoglobin ... proposed to study use of Hemopure,in patients suf...efuse,transfusion with blood components. Currently...
(Date:7/6/2008)...f Assay Submitted for FDA Clearance, SAN DIEGO, J...segment,of BD (Becton, Dickinson and Company) (NYS...D GeneOhm(TM) Cdiff molecular assay for the rapid ...nfection (CDI). It is the first CDI,diagnostic tes... one test,procedure. BD has also submitted this as...
(Date:7/3/2008)...Newswire-USNewswire/ -- All newborn infants,should...resent at birth,according to a new recommendation... recommendation and the accompanying summary of ev... Children whose hearing is impaired at birth, duri... with verbal and nonverbal communication and,socia...
Breaking Medicine Technology:Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 2Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 3Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 4Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 1Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 2Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 3Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 4Phase II Study of Zevalin 28R 29 Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 1233 5Ovarian cancer risk not affected by alcohol and smoking but reduced by caffeine 9872 1Ovarian cancer risk not affected by alcohol and smoking but reduced by caffeine 9872 2Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 1Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 2Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 3Super Thin Drug Free Coating Hides Stent as It Unblocks Heart Arteries 9870 4Deli Chef Tri Bean Salad Recalled From Some Kroger Stores 9868 1
...Point Therapeutics, Inc.,(NASDAQ: POTP) today repo... at the 2007 Annual Meeting of the American,Associ...os Angeles,California, April 14-18, 2007. The AAC...es on talabostat,s novel mechanism of action., Add...follows: , Presentation Date and Time: Monday, Apr...
... - Ascenta Therapeutics,Inc. announced today that...ing compounds will be featured in three oral,prese...week,s 2007,Annual Meeting of the American Associa... Angeles, California April 14-18, 2007., Ascenta,s...t the,"High Impact Late-Breaking Research 1" sessi...
Other Medicine Technology:Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 2Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 3Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 4Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 5Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 6
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: